Top in women’s health: High BP tied to fibroids; risks of second-stage cesarean deliveries

Among women with hypertension, the use of blood pressure medications may reduce their risk for newly diagnosed fibroids.

It was the top story in women’s health last week.

Another top story was about how second-stage cesarean deliveries may increase the risk for spontaneous preterm birth.

Read these and more top stories in women’s health below:

Untreated, new-onset hypertension tied to uterine fibroids in midlife

Both new-onset and ongoing untreated hypertension were associated with increased risks for newly diagnosed uterine fibroids among midlife women, according to findings presented at the ASRM Scientific Congress & Expo. Read more.

Second-stage cesarean deliveries may increase spontaneous preterm birth risk

Undergoing second-stage cesarian deliveries where mothers are at full cervix dilation, may increase the risk for subsequent spontaneous preterm birth vs. vaginal delivery, according to a systematic review and meta-analysis. Read more.

Obesity linked to breast cancer recurrence in women treated with aromatase inhibitors

Obesity was linked to an increased breast cancer recurrence risk among postmenopausal women with hormone receptor-positive early-stage breast cancer who were treated with aromatase inhibitors, researchers reported in JAMA Network Open. Read more.

Most hospitals do not systematically screen for social determinants of health in pregnancy

Fewer than half of hospitals participating in a maternity care quality collaborative reported systematic screening for social determinants of health in pregnancy, researchers reported in the American Journal of Obstetrics and Gynecology. Read more.

Blood loss due to uterine fibroids reduced at 2 years with relugolix combination therapy

At 2 years, women who had received relugolix combination therapy for 52 weeks and then withdrew therapy continued to have less menstrual blood loss and pain caused by uterine fibroids, researchers reported. Read more.